Zimmer Biomet To Settle Overseas Bribery Charges With US DOJ

The orthopedic device company is set to pay $17.4m to the US Department of Justice and an additional $13m to the Securities and Exchange Commission to resolve allegations that Biomet didn’t stop corrupt acts in Brazil and Mexico even after a 2012 deferred prosecution agreement.

Zimmer Biomet Holdings Inc. will pay $30.5m to settle allegations that the company’s actions in Mexico and Brazil violated the Foreign Corrupt Practices Act (FCPA), the US Department of Justice announced Jan. 12.

The payments stem from allegations that Biomet Inc. paid bribes to Mexican government officials and violated the FCPA’s internal...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Legal & IP

More from Policy & Regulation